Clinical Trial Update: BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management [Phase 3]

View source ↗

Summary

Phase 3 trial update for BLOOM study evaluating lorcaserin with behavioral modification for overweight and obesity management; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Lorcaserin (lorcaserin)

Snippet

Sponsor: Eisai Inc. | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2013-02-07